Lalmohan Maji

Lalmohan Maji

Auto-generated profile, based on publicly available information

Lalmohan Maji

Integrated Drug Discovery Centre, Department of Pharmaceutical Chemistry, Acharya & BM Reddy College of Pharmacy, Bengaluru, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
PDPrasad Sanjay Dhiwar
Prasad Sanjay Dhiwar
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada
RPROHIT PAL
ROHIT PAL
ESEkta Singh
Ekta Singh
AGAbhishek Ghara
Abhishek Ghara
GAGanesh Andhale
Ganesh Andhale
Epidermal growth factor receptor (EGFR) and its subtype human epidermal growth factor receptor 2 (HER2) gets activated when its endogenous ligand(s) bind to its ATP binding site of target receptors. In breast cancer (BC), EGFR and HER2 are two proteins are overexpressed which leads to overexpression of cells proliferation and decreases cell death/apoptosis. Pyrimidine is one of the most widely studied heterocyclic scaffolds for EGFR as well as HER2 inhibition. We gather some remarkable results for fused-pyrimidine derivatives on various cancerous cell lines (in-vitro) and animal (in-vivo) evaluation to highlight their potency. The heterocyclic (five, six-membered, etc.) moieties which are coupled with pyrimidine moiety are potent against EGFR and HER2 inhibitions. Hence structure-activity relationship (SAR) plays important role in study of heterocyclic moiety along pyrimidine and effects of substituents, groups for increase or decrease in the cancerous activity and toxicity. By thoughtful of fused pyrimidines SAR study, it facilitates in receiving excellent overview of the compounds by concerning of efficacy and potential summary for future EGFR inhibitors. Furthermore, we studied the in-silico interactions of synthesized compounds to evaluate binding affinity towards the key amino acids.. Communicated by Ramaswamy H. Sarma

20 July 2023 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
LMLalmohan Maji
Lalmohan Maji
GTGhanshyam Teli
Ghanshyam Teli
NRNulgumnalli Manjunathaiah Raghavendra
Nulgumnalli Manjunathaiah Raghavendra
SSSindhuja Sengupta
Sindhuja Sengupta
RPROHIT PAL
ROHIT PAL
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada

5 May 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
GTGhanshyam Teli
Ghanshyam Teli
RPROHIT PAL
ROHIT PAL
LMLalmohan Maji
Lalmohan Maji
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada
SSSindhuja Sengupta
Sindhuja Sengupta
The pyrimidine and fused pyrimidine ring systems play vital roles to inhibit the c-Src kinase. The Src kinase is made of different domains but the kinase domain is responsible for inhibition of Src kinase. In which the kinase domain is the main domain that is made of several amino acids. The Src kinase is inhibited by its inhibitors when it is activated by phosphorylation. Although dysregulation of Src kinase caused cancer in the late nineteenth century, medicinal chemists have not explored it extensively; therefore it is still regarded as a cult pathway. There are numerous FDA-approved drugs on the market, yet novel anticancer drugs are still in demand. Existing medications have adverse effects and drug resistance owing to rapid protein mutation. In this review, we discussed the activation process of Src kinase, chemistry of pyrimidine ring and its different synthetic routes, as well as the recent development in c-Src kinase inhibitors containing pyrimidine and their biological activity, SAR, and selectivity. The c-Src binding pocket has been predicted in detail to discover the vital amino acids which will interact with inhibitors. The potent derivatives were docked to discover the binding pattern. The derivative 2 established three hydrogen bonds with the amino acid residues Thr341 and Gln278 and had the greatest binding energy of −13.0 kcal/mol. The top docked molecules were further studied for ADMET studies. The derivative 1, 2, and 43 did not show any violation of Lipinski’s rule. All derivatives used for the prediction of toxicity showed toxicity. Graphical Abstract Communicated by Ramaswamy H. Sarma

18 January 2024 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
LMLalmohan Maji
Lalmohan Maji
SSSindhuja Sengupta
Sindhuja Sengupta
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada
GTGhanshyam Teli
Ghanshyam Teli
GBGourab Biswas
Gourab Biswas
MPManjunatha PMudagal
Manjunatha PMudagal


30 January 2025 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
SSSindhuja Sengupta
Sindhuja Sengupta
LMLalmohan Maji
Lalmohan Maji
PDPronoy Kanti Das
Pronoy Kanti Das
GTGhanshyam Teli
Ghanshyam Teli
MNMrinmoy Nag
Mrinmoy Nag
GMGurubasavaraja Swamy Purawarga Matada
Gurubasavaraja Swamy Purawarga Matada